Glial cytokine modulation improves sleep and circadian disruption in female SAA knock‐in mice of Alzheimer's‐related pathology
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Teresa Macheda und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cytokines, Circadian Rhythm, Sleep. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Sleep and circadian disturbances are early Alzheimer's disease (AD) features, yet mechanisms linking amyloid pathology, neuroinflammation, and sex differences remain unclear. METHODS We longitudinally assessed sleep, circadian rhythms, and cognition in female and male hAPP SAA knock‐in and control mice from 2 to 19 months using piezoelectric monitoring. Aged mice (15 months) received MW151, a glial cytokine inhibitor (2.5 mg/kg, every other day, 6 weeks). RESULTS Only females exhibited midlife reductions in light‐phase sleep, increased rhythm fragmentation, and reduced rhythm stability, coinciding with selective reversal learning deficits, effects independent of amyloid or cytokine burden. MW151 increased light‐phase sleep and reduced cortical TNF‐α without altering amyloid beta (Aβ) accumulation. DISCUSSION HAPP SAA mice recapitulate female‐predominant non‐cognitive AD features, including sleep fragmentation and circadian instability preceding memory deficits. Sleep improved within weeks of MW151 treatment without Aβ reductions, implicating neuroinflammatory signaling as a rapid, modifiable driver of AD‐related sleep disruption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
- Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, Kentucky, USA.
- Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
- Department of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, USA.
- Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky, USA.
- Department of Biology, University of Kentucky, Lexington, Kentucky, USA.
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Macheda, T., Hawkins, M. R., Johnson, C. E., Lapid, M. G., Whitlock, H. R., Shepard, S. M., Cox, M. F., Roberts, K. N., Bytyqi, L., Hash, H. M., El-Ezz, O. A. A., El-Ezz, M. A., Kohler, K., Sunderam, S., O'Hara, B. F., Van Eldik, L. J., Murphy, M. P., Duncan, M. J., & Bachstetter, A. D. (2026). Glial cytokine modulation improves sleep and circadian disruption in female SAA knock‐in mice of Alzheimer's‐related pathology. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71314
Vancouver
Macheda T, Hawkins MR, Johnson CE, Lapid MG, Whitlock HR, Shepard SM, et al. Glial cytokine modulation improves sleep and circadian disruption in female SAA knock‐in mice of Alzheimer's‐related pathology. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71314
BibTeX
@article{Macheda2026,
author = {Macheda, Teresa and Hawkins, Margaret R and Johnson, Carrie E and Lapid, Madison G and Whitlock, Haleigh R and Shepard, Savannah M and Cox, MaKayla F and Roberts, Kelly N and Bytyqi, Leke and Hash, Heather M and El-Ezz, Omar A Abou and El-Ezz, Mohammed Abou and Kohler, Katherina and Sunderam, Sridhar and O'Hara, Bruce F and Van Eldik, Linda J and Murphy, Michael P and Duncan, Marilyn J and Bachstetter, Adam D},
title = {Glial cytokine modulation improves sleep and circadian disruption in female SAA knock‐in mice of Alzheimer's‐related pathology},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71314}
}
EUVIMED